Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia

Published:2017-11 Issue:11 Volume:23 Page:1879-1886
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Getta Bartlomiej M.,Roshal Mikhail,Zheng Junting,Park Jae H.,Stein Eytan M.,Levine Ross,Papadopoulos Esperanza B.,Jakubowski Ann A.,Kernan Nancy A.,Steinherz Peter,O'Reilly Richard J.,Perales Miguel-Angel,Giralt Sergio A.,Tallman Martin S.,Shaffer Brian C.

Funder

National Institutes of Health

NIH/NCI Cancer Center

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference48 articles.

1. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification;Yan;Haematologica,2012

2. Acute leukemias of ambiguous origin;Porwit;Am J Clin Pathol,2015

3. Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia;Munker;Biol Blood Marrow Transplant,2016

4. Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital;Rubnitz;Blood,2009

5. Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia;Pedersen-Bjergaard;Leukemia,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia;Leukemia Research;2023-07

2. Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia;Cytometry Part B: Clinical Cytometry;2021-12-13

3. Pediatric Mixed-Phenotype Acute Leukemia: What’s New?;Cancers;2021-09-16

4. Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm;Case Reports in Hematology;2021-07-28

5. PHF6 Mutations in Hematologic Malignancies;Frontiers in Oncology;2021-07-26